Clearside Biomedical, Inc. - COM (CLSD)

Historical Portfolio Holders from Q2 2016 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
15.4 M
Holdings value Q1 2024
$23.5 M
Value change Q1 2024
+$12 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
50
Number of buys Q1 2024
31
Number of sells Q1 2024
-14
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
185063104
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 15.4 M $23.5 M +$12 M $1.53 51
2023 Q4 7.6 M $8.89 M +$29.1 K $1.17 43
2023 Q3 7.84 M $6.82 M -$748 K $0.87 44
2023 Q2 8.59 M $9.62 M -$244 K $1.12 51
2023 Q1 8.73 M $9.08 M -$468 K $1.04 46
2022 Q4 9.12 M $10.2 M -$825 K $1.12 50
2022 Q3 12.1 M $13.6 M -$1.77 M $1.13 46
2022 Q2 13.7 M $20.1 M -$4.09 M $1.47 48
2022 Q1 16.3 M $37.4 M -$12.6 M $2.29 55
2021 Q4 21 M $57.7 M -$5.52 M $2.75 61
2021 Q3 20.3 M $122 M +$4.44 M $6.00 63
2021 Q2 19.6 M $95.5 M -$3.81 M $4.87 50
2021 Q1 16 M $39.5 M +$8.5 M $2.47 50
2020 Q4 12.6 M $34.4 M +$4.19 M $2.74 38
2020 Q3 12 M $18.4 M -$33.8 K $1.54 39
2020 Q2 11.8 M $22.1 M +$524 K $1.88 41
2020 Q1 11.5 M $19.5 M +$5.91 M $1.70 36
2019 Q4 7.94 M $23 M +$2.76 M $2.90 43
2019 Q3 6.98 M $4.4 M +$1.25 M $0.63 27
2019 Q2 4.5 M $4.38 M -$1.79 M $0.97 41
2019 Q1 6.12 M $8.44 M -$8.18 M $1.38 52
2018 Q4 8.62 M $9.22 M -$28.7 M $1.07 63
2018 Q3 18.5 M $114 M -$22.8 M $6.15 84
2018 Q2 20.4 M $218 M +$7.95 M $10.69 81
2018 Q1 19.6 M $211 M +$82.1 M $10.73 79
2017 Q4 12.3 M $86.3 M -$5.59 M $7.00 51
2017 Q3 13.1 M $114 M -$1.67 M $8.74 48
2017 Q2 13.3 M $121 M +$11 M $9.11 51
2017 Q1 12 M $95.2 M +$3.41 M $7.94 57
2016 Q4 11.8 M $106 M +$35.2 M $8.94 59
2016 Q3 7.93 M $138 M +$10.6 M $17.35 29
2016 Q2 7.53 M $52.7 M +$52.7 M $7.01 16